KPC Mouse Pancreatic Cancer Cell Line

Introduction

OriCell™ KPC Mouse Pancreatic Cancer Cell Line, established by the Cyagen OriCell team through primary tissue isolation, can be used to investigate the inhibitory effects of honokiol on tumor growth in KPC mice via the SMAD2/3 signaling pathway, as well as its impact on the invasion and migration of primary tumor cells. These cells are also suitable for studies on the mechanisms of pancreatic cancer development and progression, drug screening and therapeutic research, gene function analysis, and metastasis mechanisms.

When citing our products in academic publications, please use the following format: "OriCell™ [Product Name] + [Catalog Number], from Cyagen Biosciences."

Product Information

QC

• Pass the detection of bacteria, fungi, mycoplasma, and endotoxins.
• Verified by cell recovery viability testing.
• Verified by STR analysis.

Please refer to "COA" for details.

General Handling Principles

• Maintain strict aseptic technique. Ensure complete sterility throughout all procedures, particularly within the laminar flow hood and incubator.
• Follow standardized protocols. Adhere strictly to the product manual. Implement rigorous control over experimental variables and include appropriate parallel controls.
• Use high-quality consumables and reagents. This product requires culture vessels suitable for adherent cell growth, and the reuse of these vessels is not recommended. The reagents used must be validated for reliability, cell compatibility, and batch-to-batch consistency.

Warm Notice: The cryopreservation medium of this product contains DMSO, which may pose potential risks. Please handle it with care.